Youcare Pharmaceutical Group Co Ltd
SSE:688658
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Youcare Pharmaceutical Group Co Ltd
SSE:688658
|
10B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Youcare Pharmaceutical Group Co Ltd
Glance View
Youcare Pharmaceutical Group Co Ltd has woven itself into the fabric of China’s pharmaceutical industry, standing out with its dedication to research, production, and distribution of a diverse array of healthcare products. Founded with the vision of improving health outcomes, Youcare Pharmaceuticals has strategically positioned itself within the highly competitive pharmaceutical landscape by investing heavily in innovation and quality control. With a robust R&D wing, the company channels significant resources into developing new medications and improving existing formulations, aiming to address gaps in the market and meet the pressing health needs of its population. This commitment to innovation helps Youcare stay abreast of emerging medical trends and continuously expand its product portfolio, which spans from prescription medications to over-the-counter products. The economic engine of Youcare is fueled by a well-integrated supply chain that seamlessly bridges production capabilities with widespread distribution networks. By maintaining control over these critical components, Youcare not only ensures the efficiency and reliability of its delivery but also fortifies its competitive edge in terms of cost and speed to market. This synergy is essential as it allows the company to efficiently manage production costs while adhering to the stringent regulatory standards that govern pharmaceuticals. Revenue streams are further diversified through strategic partnerships and collaborations, which enhance the company’s geographical footprint and market penetration. Consequently, Youcare Pharmaceutical Group not only strengthens its influence domestically but also draws in profits from international markets, establishing itself as a dynamic player in the global pharmaceutical industry.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Youcare Pharmaceutical Group Co Ltd is -3.1%, which is below its 3-year median of 3.7%.
Over the last 3 years, Youcare Pharmaceutical Group Co Ltd’s Net Margin has decreased from 9.9% to -3.1%. During this period, it reached a low of -3.1% on Jul 30, 2025 and a high of 9.9% on May 30, 2022.